Loading...
Loading...
Among the 4 tracked institutional investors we monitor, SDEV (NOVABAY PHARMACEUTICALS INC) is held with a combined value of $928.71K across 623,295 shares. The largest holder is BlackRock, Inc. with a position worth $630.78K (0.00% of their portfolio). 4 funds opened new positions in the most recent quarter.
Total Institutional Value
$928.71K
Total Shares Held
623,295
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $630.78K | 0.00% | New |
| 2 | STATE STREET CORP | $174.56K | 0.00% | New |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $123.36K | 0.00% | New |
| 4 | FMR LLC | $4 | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of SDEV with a position worth $630.78K, representing 0.00% of their portfolio. In total, 4 institutional investors hold SDEV with a combined value of $928.71K.
In the most recent quarter, 4 funds opened a new position in SDEV.
Institutional investors hold $928.71K worth of SDEV stock across 4 positions. The largest institutional holder is BlackRock, Inc. with $630.78K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SDEV, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SDEV positions.